Hexagon Capital Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-3,181
| Closed | -$286K | – | 1048 |
|
2025
Q1 | $286K | Sell |
3,181
-375
| -11% | -$33.7K | 0.05% | 164 |
|
2024
Q4 | $284K | Buy |
3,556
+456
| +15% | +$36.4K | 0.05% | 160 |
|
2024
Q3 | $279K | Sell |
3,100
-6
| -0.2% | -$540 | 0.05% | 165 |
|
2024
Q2 | $244K | Buy |
3,106
+244
| +9% | +$19.2K | 0.05% | 171 |
|
2024
Q1 | $249K | Sell |
2,862
-396
| -12% | -$34.5K | 0.06% | 169 |
|
2023
Q4 | $268K | Buy |
3,258
+456
| +16% | +$37.6K | 0.06% | 155 |
|
2023
Q3 | $220K | Sell |
2,802
-229
| -8% | -$17.9K | 0.06% | 160 |
|
2023
Q2 | $267K | Buy |
3,031
+273
| +10% | +$24.1K | 0.07% | 132 |
|
2023
Q1 | $222K | Buy |
2,758
+142
| +5% | +$11.4K | 0.06% | 149 |
|
2022
Q4 | $203K | Buy |
2,616
+757
| +41% | +$58.8K | 0.06% | 152 |
|
2022
Q3 | $150K | Buy |
1,859
+573
| +45% | +$46.2K | 0.04% | 183 |
|
2022
Q2 | $115K | Buy |
1,286
+334
| +35% | +$29.9K | 0.03% | 246 |
|
2022
Q1 | $106K | Buy |
952
+3
| +0.3% | +$334 | 0.03% | 264 |
|
2021
Q4 | $98K | Buy |
949
+80
| +9% | +$8.26K | 0.03% | 271 |
|
2021
Q3 | $109K | Buy |
869
+20
| +2% | +$2.51K | 0.03% | 234 |
|
2021
Q2 | $105K | Hold |
849
| – | – | 0.03% | 242 |
|
2021
Q1 | $100K | Sell |
849
-105
| -11% | -$12.4K | 0.03% | 230 |
|
2020
Q4 | $111K | Hold |
954
| – | – | 0.03% | 173 |
|
2020
Q3 | $97K | Buy |
+954
| New | +$97K | 0.03% | 180 |
|